Results 301 to 310 of about 370,325 (328)
Some of the next articles are maybe not open access.

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis.

The Lancet, 2021
Psoriasis is a chronic inflammatory disease characterised by sharply demarcated erythematous and scaly skin lesions accompanied by systemic manifestations.
K. Ghoreschi   +3 more
semanticscholar   +1 more source

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review.

Journal of the American Medical Association (JAMA), 2020
Importance Approximately 125 million people worldwide have psoriasis. Patients with psoriasis experience substantial morbidity and increased rates of inflammatory arthritis, cardiometabolic diseases, and mental health disorders.
A. Armstrong, C. Read
semanticscholar   +1 more source

Psoriasis

Drugs of Today, 1998
Psoriasis is an inflammatory disorder of the skin that involves complex interactions between the dermis and epidermis. There are several forms of psoriasis, the most common being plaque type psoriasis. Other forms include guttate, pustular and erythrodermic psoriasis. Both the skin and joints are affected in this disease.
M H, Tan, M, Lebwohl
openaire   +4 more sources

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

Journal of American Academy of Dermatology, 2019
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available ...
A. Menter   +31 more
semanticscholar   +1 more source

Psoriasis

The Lancet, 1906
Psoriasis is an immune-mediated inflammatory cutaneous disorder characterized by chronic, scaling, erythematous patches and plaques of skin. It can begin at any age and can vary in severity.
R. V. Patel, Mark G. Lebwohl
semanticscholar   +1 more source

Pathophysiology of psoriasis: A review

Journal of dermatology (Print), 2021
Psoriasis is a complex chronic inflammatory skin disease caused by the dynamic interplay between multiple genetic risk foci, environmental risk factors, and excessive immunological abnormalities.
K. Yamanaka, O. Yamamoto, T. Honda
semanticscholar   +1 more source

Joint Aad-Npf Guidelines Of Care For The Management Of Psoriasis With Systemic Non-Biological Therapies.

Journal of American Academy of Dermatology, 2020
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approximately 2% of the world's population. In this guideline, we focus the discussion on systemic, non-biologic medications for the treatment of this disease.
A. Menter   +33 more
semanticscholar   +1 more source

Psoriasis

2008
Psoriasis is one of the most common chronic inflammatory disorders with a strong genetic background. Recent progress in the understanding of both the immunological as well as the genetic basis has provided an unprecedented opportunity to move scientific insights from the bench to bedside.
openaire   +2 more sources

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.

Journal of American Academy of Dermatology, 2019
Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations on the basis of available
C. Elmets   +31 more
semanticscholar   +1 more source

Psoriasis

The Lancet, 1995
Psoriasis, an inherited disorder of the immune system, presents most commonly in the skin and joints but is also associated with cardiovascular, metabolic, and neuropsychiatric effects. Treatments include topical therapy for mild disease; phototherapy and oral therapy, such as retinoids and immunomodulating agents; and targeted biologic therapies that ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy